Allianz Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.95M | Buy |
211,800
+3,800
| +2% | +$101K | 0.01% | 1077 |
|
|
2025
Q4 | $5.18M | Buy |
208,000
+61,300
| +42% | +$1.55M | 0.01% | 1127 |
|
|
2025
Q3 | $3.74M | Sell |
146,700
-71,600
| -33% | -$1.77M | ﹤0.01% | 1237 |
|
|
2025
Q2 | $5.29M | Buy |
218,300
+33,600
| +18% | +$784K | 0.01% | 1091 |
|
|
2025
Q1 | $4.68M | Buy |
184,700
+48,900
| +36% | +$1.28M | 0.01% | 1148 |
|
|
2024
Q4 | $3.6M | Sell |
135,800
-59,500
| -30% | -$1.61M | ﹤0.01% | 1185 |
|
|
2024
Q3 | $5.65M | Buy |
195,300
+85,900
| +79% | +$2.51M | 0.01% | 983 |
|
|
2024
Q2 | $3.06M | Buy |
109,400
+103,400
| +1,723% | +$2.85M | ﹤0.01% | 1154 |
|
|
2024
Q1 | $167K | Sell |
6,000
-149,200
| -96% | -$4.14M | ﹤0.01% | 1872 |
|
|
2023
Q4 | $4.47M | Sell |
155,200
-185,700
| -54% | -$5.61M | 0.01% | 970 |
|
|
2023
Q3 | $11.3M | Buy |
340,900
+209,700
| +160% | +$7.42M | 0.02% | 682 |
|
|
2023
Q2 | $4.81M | Sell |
131,200
-90,200
| -41% | -$3.51M | 0.01% | 881 |
|
|
2023
Q1 | $9.03M | Sell |
221,400
-33,500
| -13% | -$1.45M | 0.02% | 729 |
|
|
2022
Q4 | $13.1M | Buy |
254,900
+59,900
| +31% | +$2.87M | 0.03% | 599 |
|
|
2022
Q3 | $8.53M | Buy |
195,000
+165,500
| +561% | +$8.04M | 0.02% | 705 |
|
|
2022
Q2 | $1.55M | Sell |
29,500
-89,400
| -75% | -$4.56M | ﹤0.01% | 1515 |
|
|
2022
Q1 | $6.16M | Buy |
118,900
+8,600
| +8% | +$446K | ﹤0.01% | 1150 |
|
|
2021
Q4 | $6.51M | Sell |
110,300
-265,700
| -71% | -$13.2M | ﹤0.01% | 1140 |
|
|
2021
Q3 | $16.2M | Buy |
376,000
+274,800
| +272% | +$12.2M | 0.01% | 816 |
|
|
2021
Q2 | $3.96M | Buy |
+101,200
| New | +$3.94M | ﹤0.01% | 1217 |
|
|
2020
Q3 | – | Sell |
-141,341
| Closed | -$4.38M | – | 2273 |
|
|
2020
Q2 | $4.38M | Sell |
141,341
-33,623
| -19% | -$1.14M | 0.01% | 1263 |
|
|
2020
Q1 | $5.42M | Sell |
174,964
-387,556
| -69% | -$13.2M | 0.01% | 1131 |
|
|
2019
Q4 | $20.9M | Sell |
562,520
-9,802
| -2% | -$349K | 0.02% | 771 |
|
|
2019
Q3 | $19.5M | Sell |
572,322
-39,525
| -6% | -$1.44M | 0.02% | 784 |
|
|
2019
Q2 | $25.1M | Buy |
611,847
+199,944
| +49% | +$7.94M | 0.02% | 710 |
|
|
2019
Q1 | $16.6M | Buy |
411,903
+342,128
| +490% | +$13.7M | 0.02% | 844 |
|
|
2018
Q4 | $2.89M | Sell |
69,775
-269,191
| -79% | -$11.2M | ﹤0.01% | 1619 |
|
|
2018
Q3 | $14.2M | Sell |
338,966
-43,214
| -11% | -$1.66M | 0.01% | 1090 |
|
|
2018
Q2 | $13.2M | Sell |
382,180
-198,363
| -34% | -$6.78M | 0.01% | 1126 |
|
|
2018
Q1 | $19.5M | Sell |
580,543
-786,811
| -58% | -$27M | 0.02% | 895 |
|
|
2017
Q4 | $47M | Sell |
1,367,354
-477,989
| -26% | -$16.3M | 0.04% | 563 |
|
|
2017
Q3 | $62.5M | Buy |
1,845,343
+217,335
| +13% | +$6.99M | 0.05% | 420 |
|
|
2017
Q2 | $51.9M | Sell |
1,628,008
-43,425
| -3% | -$1.37M | 0.05% | 468 |
|
|
2017
Q1 | $54.3M | Buy |
1,671,433
+125,847
| +8% | +$3.97M | 0.05% | 447 |
|
|
2016
Q4 | $47.6M | Buy |
1,545,586
+239,048
| +18% | +$7.3M | 0.04% | 565 |
|
|
2016
Q3 | $42M | Buy |
1,306,538
+498,120
| +62% | +$16.7M | 0.04% | 552 |
|
|
2016
Q2 | $27M | Buy |
808,418
+490,742
| +154% | +$15.7M | 0.03% | 734 |
|
|
2016
Q1 | $8.93M | Buy |
317,676
+31,304
| +11% | +$894K | 0.01% | 1185 |
|
|
2015
Q4 | $8.77M | Buy |
286,372
+67,562
| +31% | +$2.13M | 0.01% | 1116 |
|
|
2015
Q3 | $6.52M | Sell |
218,810
-211,011
| -49% | -$6.77M | 0.01% | 1169 |
|
|
2015
Q2 | $13.7M | Buy |
429,821
+96,968
| +29% | +$3.16M | 0.01% | 961 |
|
|
2015
Q1 | $11M | Sell |
332,853
-44,057
| -12% | -$1.4M | 0.01% | 918 |
|
|
2014
Q4 | $11.1M | Buy |
376,910
+266,135
| +240% | +$7.63M | 0.01% | 919 |
|
|
2014
Q3 | $3.11M | Buy |
110,775
+108,772
| +5,430% | +$3.05M | ﹤0.01% | 1259 |
|
|
2014
Q2 | $56K | Buy |
+2,003
| New | +$57.1K | ﹤0.01% | 1914 |
|
Other funds holding PFE
VCM
VPM
Allianz Asset Management's PFE Position: Q1 2026 in Review
Allianz Asset Management reduced its Pfizer (PFE) stake by 4.1% in Q1 2026, selling an estimated $6.17M and leaving 5,490,142 shares worth $154M. The position accounts for 0.16% of the portfolio, ranked #121.
Allianz Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $942M in Q2 2013. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Allianz Asset Management held 5,490,142 shares of Pfizer worth $154M as of Q1 2026.
- Allianz Asset Management sold 231,784 Pfizer shares in Q1 2026, an estimated $6.17M.
- Pfizer made up 0.16% of Allianz Asset Management's portfolio in Q1 2026, its #121 holding.
- Allianz Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Pfizer position peaked at $942M in Q2 2013.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.